English
Deutsch
Español
Français
Magyar
Italiano
日本語
한국어
Nederland
Język polski
Português (PT)
Русский язык
简体中文
繁體中文
Türkçe
Kathmandu, Nepal - November 24 2020: Syringe Injection infront of AstraZeneca Logo. AstraZeneca vaccine has shown 90% effectiveness against COVID-19 in Phase 3 of human trial. - 159562123

Kathmandu, Nepal - November 24 2020: Syringe Injection infront of AstraZeneca Logo. AstraZeneca vaccine has shown 90% effectiveness against COVID-19 in Phase 3 of human trial.

 159562123

Benzer görseller